Novartis Investigative Site

Dinslaken 46535

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerosis, Heart Failure With Reduced Ejection Fraction (HF-rEF)

Studies at this site

• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed